TY - JOUR
T1 - Chronic kidney disease after heart transplantation: a single-centre retrospective study at skåne university hospital in lund 1988-2010.
AU - Söderlund, Carl
AU - Löfdahl, Eveline
AU - Nilsson, Johan
AU - Reitan, Öyvind
AU - Higgins, Thomas
AU - Rådegran, Göran
PY - 2016
Y1 - 2016
N2 - We aimed to study the incidence, predictors, and outcome of chronic kidney disease (CKD) after heart transplantation (HT). All our HT patients 1988-2010 were considered for inclusion. Of these, 134 came for annual follow-ups including evaluation of glomerular filtration rate (GFR) using iohexol clearance measurements, and the CKD-EPI (adults) or Schwartz (children) formulae. Median GFR (Q1-Q3)(mL/min/1.73m(2) ) declined from 67.0 (50.0-82.0) during transplant assessment (TA), to 56.0 (45.0-69.0) at year 1, 53.0 (41.0-68.0) at year 5 and 44.5 (25.0-57.3) at year 10. The cumulative incidence of CKD ≥ stage 4 was 25% at 5 years and 41% at 10 years after transplantation. Proteinuria the first year post-HT was the only predictor related (p<0.05) to a higher rate of GFR decline (HR 5.15, 95% CI 1.23-21.55). GFR ≥60 as compared to <60 before HT, or a first year GFR decline <30% as compared to >30%, was moreover associated (p<0.05) with a lower risk of death (HR 0.30, 95% CI 0.12-0.76 and HR 0.35, 95% CI 0.13-0.90, respectively). Notably, the CKD-EPI and Schwartz formulae overestimated GFR by 28±29% and 26±33%, respectively. In conclusion, CKD in HT patients is common and associated with worse outcome. To avoid diagnostic delay, GFR estimating equation's validity in HT patients needs further study. This article is protected by copyright. All rights reserved.
AB - We aimed to study the incidence, predictors, and outcome of chronic kidney disease (CKD) after heart transplantation (HT). All our HT patients 1988-2010 were considered for inclusion. Of these, 134 came for annual follow-ups including evaluation of glomerular filtration rate (GFR) using iohexol clearance measurements, and the CKD-EPI (adults) or Schwartz (children) formulae. Median GFR (Q1-Q3)(mL/min/1.73m(2) ) declined from 67.0 (50.0-82.0) during transplant assessment (TA), to 56.0 (45.0-69.0) at year 1, 53.0 (41.0-68.0) at year 5 and 44.5 (25.0-57.3) at year 10. The cumulative incidence of CKD ≥ stage 4 was 25% at 5 years and 41% at 10 years after transplantation. Proteinuria the first year post-HT was the only predictor related (p<0.05) to a higher rate of GFR decline (HR 5.15, 95% CI 1.23-21.55). GFR ≥60 as compared to <60 before HT, or a first year GFR decline <30% as compared to >30%, was moreover associated (p<0.05) with a lower risk of death (HR 0.30, 95% CI 0.12-0.76 and HR 0.35, 95% CI 0.13-0.90, respectively). Notably, the CKD-EPI and Schwartz formulae overestimated GFR by 28±29% and 26±33%, respectively. In conclusion, CKD in HT patients is common and associated with worse outcome. To avoid diagnostic delay, GFR estimating equation's validity in HT patients needs further study. This article is protected by copyright. All rights reserved.
U2 - 10.1111/tri.12710
DO - 10.1111/tri.12710
M3 - Article
C2 - 26531026
SN - 1432-2277
VL - 29
SP - 529
EP - 539
JO - Transplant international : official journal of the European Society for Organ Transplantation
JF - Transplant international : official journal of the European Society for Organ Transplantation
IS - 5
ER -